Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cell populations

Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, but preclinical studies in large animal models are required to determine optimal cell preparation and delivery strategies to maximize functional benefits and to evaluate safety. Here, we utilized a por...

Full description

Saved in:
Bibliographic Details
Published in:Cell stem cell 2014-12, Vol.15 (6), p.750-761
Main Authors: Ye, Lei, Chang, Ying-Hua, Xiong, Qiang, Zhang, Pengyuan, Zhang, Liying, Somasundaram, Porur, Lepley, Mike, Swingen, Cory, Su, Liping, Wendel, Jacqueline S., Guo, Jing, Jang, Albert, Rosenbush, Daniel, Greder, Lucas, Dutton, James R., Zhang, Jianhua, Kamp, Timothy J., Kaufman, Dan S., Ge, Ying, Zhang, Jianyi
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, but preclinical studies in large animal models are required to determine optimal cell preparation and delivery strategies to maximize functional benefits and to evaluate safety. Here, we utilized a porcine model of acute myocardial infarction (MI) to investigate the functional impact of intramyocardial transplantation of hiPSC-derived cardiomyocytes, endothelial cells, and smooth muscle cells, in combination with a 3D fibrin patch loaded with insulin growth factor (IGF)-encapsulated microspheres. hiPSC-derived cardiomyocytes integrated into host myocardium and generated organized sarcomeric structures, and endothelial and smooth muscle cells contributed to host vasculature. Tri-lineage cell transplantation significantly improved left ventricular function, myocardial metabolism, and arteriole density, while reducing infarct size, ventricular wall stress and apoptosis without inducing ventricular arrhythmias. These findings in a large animal MI model highlight the potential of utilizing hiPSC-derived cells for cardiac repair.
ISSN:1934-5909
1875-9777
DOI:10.1016/j.stem.2014.11.009